Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines

J. Bentzen; Jørgen Johansen; C. A. Kristensen; M. Overgaard; L. Andersen; J. Overgaard

Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines

J. Bentzen, Jørgen Johansen, C. A. Kristensen, M. Overgaard, L. Andersen, J. Overgaard

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning

Originalsprog	Engelsk
Publikationsdato	2008
Status	Udgivet - 2008
Begivenhed	ESTRO - European Society for Therapeutic Radiology and Oncology - Gøteborg, Sverige Varighed: 14. sep. 2008 → 18. sep. 2008 Konferencens nummer: 27

Konference

Konference	ESTRO - European Society for Therapeutic Radiology and Oncology
Nummer	27
Land	Sverige
By	Gøteborg
Periode	14/09/2008 → 18/09/2008

Citationsformater

Bentzen, J., Johansen, J., Kristensen, C. A., Overgaard, M., Andersen, L., & Overgaard, J. (2008). Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines. Poster session præsenteret på ESTRO - European Society for Therapeutic Radiology and Oncology, Gøteborg, Sverige.

Bentzen, J. ; Johansen, Jørgen ; Kristensen, C. A. ; Overgaard, M. ; Andersen, L. ; Overgaard, J. / Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines. Poster session præsenteret på ESTRO - European Society for Therapeutic Radiology and Oncology, Gøteborg, Sverige.

@conference{d0ababf0a01211dd9b31000ea68e967b,

title = "Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines",

author = "J. Bentzen and J{\o}rgen Johansen and Kristensen, {C. A.} and M. Overgaard and L. Andersen and J. Overgaard",

year = "2008",

language = "English",

note = "null ; Conference date: 14-09-2008 Through 18-09-2008",

}

Bentzen, J, Johansen, J, Kristensen, CA, Overgaard, M, Andersen, L & Overgaard, J 2008, 'Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines', ESTRO - European Society for Therapeutic Radiology and Oncology, Gøteborg, Sverige, 14/09/2008 - 18/09/2008.

Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines. / Bentzen, J.; Johansen, Jørgen; Kristensen, C. A.; Overgaard, M.; Andersen, L.; Overgaard, J.

2008. Poster session præsenteret på ESTRO - European Society for Therapeutic Radiology and Oncology, Gøteborg, Sverige.

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning

TY - CONF

T1 - Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines

AU - Bentzen, J.

AU - Johansen, Jørgen

AU - Kristensen, C. A.

AU - Overgaard, M.

AU - Andersen, L.

AU - Overgaard, J.

N1 - Conference code: 27

PY - 2008

Y1 - 2008

M3 - Poster

Y2 - 14 September 2008 through 18 September 2008

ER -

Bentzen J, Johansen J, Kristensen CA, Overgaard M, Andersen L, Overgaard J. Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum. Results from the first 45 patients treated according to the DAHANCA 14 guidelines. 2008. Poster session præsenteret på ESTRO - European Society for Therapeutic Radiology and Oncology, Gøteborg, Sverige.